We are live on
!
Find out more
CGM
Capital Growth Management Portfolio holdings
AUM
$761M
1-Year Est. Return
30.71%
This Fund
S&P 500
This Quarter
Est. Return
-4.32%
1 Year Est. Return
+30.71%
3 Year Est. Return
+422.09%
5 Year Est. Return
+672.61%
10 Year Est. Return
–
AUM
$1.6B
AUM Growth
-$338M
(-17%)
Cap. Flow
-$202M
Cap. Flow
% of AUM
-12.68%
Top 10 Holdings %
Top 10 Hldgs %
54.82%
Holding
72
New
19
Increased
18
Reduced
13
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Santander
BSBR
|
+$56.9M |
| 2 |
Jazz Pharmaceuticals
JAZZ
|
+$49M |
| 3 |
Ambev
ABEV
|
+$43.5M |
| 4 |
WLL
Whiting Petroleum Corporation
WLL
|
+$41.1M |
| 5 |
Phillips 66
PSX
|
+$38.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gerdau
GGB
|
+$84.2M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$62.5M |
| 3 |
TIF
Tiffany & Co.
TIF
|
+$59.3M |
| 4 |
Celanese
CE
|
+$45.6M |
| 5 |
JPMorgan Chase
JPM
|
+$44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 24.5% |
| 2 | Financials | 20.63% |
| 3 | Energy | 17.93% |
| 4 | Materials | 11.62% |
| 5 | Consumer Discretionary | 7.68% |
Similar funds
AEPI
PS
BO
RIM
FF
BCM
RWA
HPWM
Capital Growth Management's Q4 2018 Portfolio in Review
As of Q4 2018, Capital Growth Management held 72 positions worth $1.6B, down 17% from $1.93B the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Capital Growth Management withdrew a net $202M in Q4 2018, closing 21 positions and reducing 13 holdings. Its most notable exit was Gerdau, an estimated $84.2M position sold in full.
By sector, the portfolio is most concentrated in Real Estate at 24% of assets, up from 13% a quarter earlier, followed by Financials and Energy.
Against the trend, Capital Growth Management opened a new position in Santander worth $57.6M.
- Capital Growth Management's largest Q4 2018 buy was Santander: 5,402,700 shares worth $57.6M.
- Capital Growth Management added most to Whiting Petroleum Corporation in Q4 2018, an estimated $41.1M increase.
- Capital Growth Management's biggest Q4 2018 reduction was Eli Lilly, cutting an estimated $39.7M.
- Capital Growth Management fully exited Gerdau in Q4 2018, selling an estimated $84.2M.
- Capital Growth Management's ten largest holdings make up 55% of its $1.6B portfolio in Q4 2018.
- Capital Growth Management opened 19 new positions and closed 21 in Q4 2018.
- Capital Growth Management's portfolio value fell 17% quarter-over-quarter to $1.6B.
Based on Capital Growth Management's 13F filing for Q4 2018, filed 14 Feb 2019.